However, this approach allowed us to highlight that the high expression of FOXO6 was a marker of poor prognostic in our subpopulation of breast tumors HR- and ERBB2- (triple negative breast tumors) (p = 0.0053, Figure 3). This evidence concerns the gene ERBB2 and breast neoplasm.